The Food and Drug Administration (FDA) Determines that Women Taking Addyi May Safely Consume Alcohol
This decision was informed by three new Addyi alcohol interaction studies which demonstrated no syncope or orthostatic hypotension requiring medical attention.
- This decision was informed by three new Addyi alcohol interaction studies which demonstrated no syncope or orthostatic hypotension requiring medical attention.
- Sprout received the FDA ordered Addyi labeling change to lessen the alcohol restriction on April 11, 2019.
- "FDA, like us, recognizes that women want access to treatment for this condition and their label order reflecting that women taking Addyi may safely consume alcohol is a positive step.
- Addyi is the first and only FDA-approved treatment for acquired, generalized hypoactive (low) sexual desire disorder (HSDD) for premenopausal women.